References
- Borody T J, Cole P, Noonan S, Morgan A, Lenne J, Hyland L, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Austr 1989; 151: 431–5
- Forman D, Newell D G, Fullerton F, Yarnell J W G, Stacey A R, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302–5
- Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1988; 96: 615–25
- Marshall B J, Armstrong J A, McGechie D B, Glancy R J. Attempt to fulfil Koch's postulates for pyloric campylobacter. Med J Austr 1985; 142: 436–9
- Marshall B J, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311–4
- Parsonnet J, Freidman G D, Vandersteen D P, Chang Y, Vogelman J H, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31
- Sipponen P, Kekki M, Siurala M. The Sydney system: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 1991; 6: 244–51
- Vigneri S, Termini R, Scialabba A, DiMario F, Savarino V, Mela G S. One year relapse rate after H pylori eradication with omeprazole plus antimicrobials. Gastroenterology 1993; 104: A220
- McNulty C A, Dent J C. Susceptibility of clinical isolates of Campylobacter pylori to twenty‐one antimicrobial agents. Eur J Clin Microbial Infect Dis 1988; 7: 566–9
- Chiba N, Rao B V, Rademaker J W, Hunt R H. Meta‐analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 87: 1716–27
- Labenz J, Gyenes E, Rühl G H, Börsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993; 88: 491–5
- Cantorna M T. Inability of human clinical strains of Helicobacter pylori to colonize the alimentary tract of germfree rodents. Can J Microbiol 1989; 36: 237–41
- Ehlers S, Warrelmann M, Hahn H. In search of an animal model for experimental Campylobacter pylori infection: administration of Campylobacter to rodents. Zbl Bakt Hyg 1988; A268: 341–6
- Engstrand L, Gustavsson S, Jörgensen A, Schwan A, Scheynius A. Inoculation of barrier‐born pigs with Helicobacter pylori: a useful animal model for gastritis type B. Infect Immun 1990; 58: 1763–8
- Engstrand L, Rosberg K, Hübinette R, Berglindh T, Rolfsen W, Gustavsson S. Topographic mapping of Helicobacter pylori colonization in long‐term infected pigs. Infect Immun 1992; 60: 653–6
- Krakowka S, Morgan D R, Kraft W G, Leunk R D. Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet. Infect Immun 1987; 55: 2789–96
- Meyer‐Rosberg K, Gustavsson S. 13C‐urea breath test for diagnosis of experimental Helicobacter pylori infection in barrier born pigs. Gut 1992; 34: 594–8
- Karita M, Kouchiyama T, Okita K, Nakazawa T. New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice. Am J Gastroenterol 1991; 86: 1596–602
- Marchetti M, Arico B, Burroni D, Figure N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655–8
- Rosberg K, Hübinette R, Nygård G, Berglindh T, Rolfsen W. Studies of Helicobacter pylori in a gastric mucosa in vitro animal model. Scand J Gastroenterol 1991; 26: 43–8
- Rosberg K, Berglindh T, Gustavsson S, Hübinette R, Rolfsen W. Adhesion of Helicobacter pylori to human gastric mucosal biopsy specimens cultivated in vitro. Scand J Gastroenterol 1991; 26: 1179–87
- Meyer‐Rosberg K, Berglindh T. Helicobacter colonization of biopsy specimens cultured in vitro is dependent on both mucosal type and bacterial strain. Scand J Gastroenterol 1996; 31: 434–41
- Gilbert J C, Hadgraft J, Bye A, Brooks L G. Drug release from Pluronic F‐127 gels. Int J Pharm 1986; 32: 223–8
- Sjöström J E, Berlund M L, Fryklund J, Kuhler T, Larsson H. Factors affecting antibacterial activity of omeprazole and structural analogues in vitro. Acta Gastroenterol Belg 1993; 56: 144, Suppl
- Fauchère J ‐L, Blaser M J. Adherence of Helicobacter pylori cells and their surface components to HeLa cell membranes. Microb Pathogen 1990; 9: 427–39
- Evans D G, Evans D J, Graham D Y. Receptor‐mediated adherence of Campylobacter pylori to mouse Y‐1 adrenal cell monolayers. Infect Immun 1989; 57: 2272–8
- Neman‐Simha V, Megraud F. In vitro model for Campylobacter pylori adherence properties. Infect Immun 1988; 56: 23329–33
- Smoot D T, Resau J H, Naab T, Desbordes B C, Gilliam T, Bullhenry K, et al. Adherence of Helicobacter pylori to cultured human gastric epithelial cells. Infect Immun 1993; 61: 350–5
- Clyne M, Drumm B. Adherence of Helicobacter pylori to primary human gastrointestinal cells. Infect Immun 1993; 61: 4051–7
- Lingwood C A, Law H, Pellizzari A, Sherman P, Drumm B. Gastric glycerolipid as a receptor for Campylobacter pylori. Lancet 1989; 2: 238–41
- Atherton J C, Cockayne A, Balsitis M, Kirk G E, Hawkey C J, Spiller R C. Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxicillin and cimetidine. Gut 1995; 36: 670–4